11-Dehydrothromboxane is produced from the breakdown of?thromboxane A2. It is released by activated platelets and urine levels of 11-dehydro-TXB2 can be used to monitor the response to?aspirin?therapy when used to prevent heart disease?and in diseases where platelet activation is prominent.